GO:0042426 choline catabolic process: Choline Breakdown Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0042426 choline catabolic process describes the biochemical reactions that break down choline (2-hydroxyethyltrimethylammonium), an amino alcohol essential for phospholipid synthesis and acetylcholine production.
• Choline catabolism intersects with the CDP-choline (Kennedy) pathway, where choline is first phosphorylated and then converted to CDP-choline for phosphatidylcholine synthesis, with catabolic steps recycling choline from membrane lipids.
• Dysregulated choline metabolism is a metabolic hallmark of cancer, where elevated phosphocholine and total choline compounds are detectable by magnetic resonance spectroscopy.
• Choline is an essential nutrient; its catabolic and anabolic pathways are tightly linked to folate-mediated one-carbon metabolism and methyl-group shuttling.
• Genetic and dietary perturbations of choline catabolic genes alter lipid droplet accumulation, tumorigenesis, and neurocognitive outcomes.
• CRISPR knockout, point-mutation, knock-in, and overexpression models enable causal dissection of choline catabolic enzymes in disease and development.
Description
Choline catabolic process (GO:0042426) is the set of chemical reactions and pathways that result in the breakdown of choline (2-hydroxyethyltrimethylammonium), an amino alcohol that occurs widely in living organisms as a constituent of certain phospholipids and in the neurotransmitter acetylcholine. Choline is an essential nutrient and a precursor for phosphatidylcholine, sphingomyelin, and acetylcholine, and its catabolism is intimately connected to the CDP-choline cycle and one-carbon metabolism. Understanding choline catabolism is therefore central to lipid biochemistry, neurobiology, and cancer metabolism. At the cellular level, choline catabolic process encompasses enzymatic steps that degrade choline or its phosphorylated intermediates, releasing methyl groups and carbon units for reuse. These reactions are interlinked with the Kennedy pathway for phosphatidylcholine biosynthesis, where choline is phosphorylated by choline kinase and subsequently converted to CDP-choline. Catabolic recycling of choline from phosphatidylcholine by phospholipases feeds back into this pool, making choline catabolism a node of metabolic flexibility. For researchers, GO:0042426 provides a framework to study how choline breakdown influences membrane lipid composition, methyl-donor availability, and signaling. Perturbations in choline catabolic flux have been linked to altered lipid droplet dynamics, tumorigenesis, and neurodevelopmental outcomes. This article synthesizes the definition, mechanism, key genes, disease relevance, and CRISPR-based research strategies for choline catabolic process.
choline catabolic process At A Glance
| GO ID | GO:0042426 |
|---|---|
| GO term | choline catabolic process |
| Ontology | biological_process |
| Synonym | choline breakdown; choline catabolism; choline degradation |
| Major function | Breakdown of choline and its phosphorylated intermediates, recycling methyl groups and carbon units for one-carbon metabolism and lipid homeostasis |
| Related pathway | CDP-choline (Kennedy) pathway for phosphatidylcholine synthesis |
| Key enzymes | Choline kinase, CTP:phosphocholine cytidylyltransferase, phospholipases, choline dehydrogenase, betaine aldehyde dehydrogenase |
| Disease relevance | Cancer metabolic reprogramming, neurodevelopmental disorders, cardiometabolic disease |
| Research methods | CRISPR KO/point mutation/knock-in/overexpression, metabolomics, MRS, RNA-seq, proteomics |
What Is GO:0042426?
The choline catabolic process (GO:0042426) is defined as the chemical reactions and pathways resulting in the breakdown of choline (2-hydroxyethyltrimethylammonium), an amino alcohol that occurs widely in living organisms as a constituent of certain types of phospholipids and in the neurotransmitter acetylcholine. In practice, this includes enzymatic dephosphorylation, oxidation, and demethylation steps that convert choline or its phosphorylated derivatives into downstream metabolites such as betaine, glycine, and methyl-group donors, as well as phospholipase-mediated release of choline from phosphatidylcholine for subsequent degradation.
Why Is choline catabolic process Important in Cell Biology?
Choline catabolic process is important because it sits at the intersection of membrane lipid synthesis, methyl-group metabolism, and neurotransmitter production. Choline is an essential nutrient, and its breakdown products feed into folate-mediated one-carbon metabolism, influencing DNA methylation and epigenetic regulation. In cancer, altered choline catabolism and phosphatidylcholine turnover contribute to lipid droplet accumulation and tumorigenesis, and choline metabolites are used as non-invasive biomarkers. In neurodevelopment, choline catabolic flux affects acetylcholine availability and cognitive outcomes. Thus, GO:0042426 is a critical node for understanding metabolic disease, cancer, and brain function.
• Choline catabolism supplies methyl groups for one-carbon metabolism, linking diet to epigenetic regulation.
• It is required for phosphatidylcholine turnover and membrane lipid homeostasis.
• Dysregulated choline metabolism is a metabolic hallmark of cancer detectable by MRS.
• p53 suppresses lipid droplet-fueled tumorigenesis through phosphatidylcholine metabolism, implicating choline catabolic flux.
• Choline is essential for neurodevelopment and cognitive function, with catabolic pathways affecting acetylcholine synthesis.
• Choline catabolic genes are candidate targets for cardiometabolic and neurodegenerative disease research.
• CRISPR screens can identify synthetic lethal interactions with choline catabolic enzymes in cancer.
• Choline breakdown intersects with folate and methionine cycles, affecting global methylation.
• Altered choline catabolism contributes to lipid droplet accumulation in tumors.
• Understanding choline catabolism informs nutritional guidelines and therapeutic strategies.
What Happens During choline catabolic process?
Choline uptake and phosphorylation
In simple terms: Choline enters the cell and gets a phosphate group added, preparing it for further reactions.
Choline is transported into cells by specific transporters and rapidly phosphorylated by choline kinase to phosphocholine, the first step in the CDP-choline pathway. This phosphorylation also represents a branch point: phosphocholine can be used for phosphatidylcholine synthesis or further catabolized. Choline transport for phospholipid synthesis is a regulated process that determines substrate availability for both anabolic and catabolic routes.
Conversion to CDP-choline and phosphatidylcholine synthesis
In simple terms: Phosphocholine is activated and combined with a lipid backbone to make phosphatidylcholine, a major membrane lipid.
Phosphocholine is converted to CDP-choline by CTP:phosphocholine cytidylyltransferase, the rate-limiting enzyme of the Kennedy pathway, and then to phosphatidylcholine via choline phosphotransferase. This pathway is the primary consumer of choline for membrane biogenesis. Catabolic recycling of phosphatidylcholine by phospholipases releases choline and phosphocholine, feeding back into the catabolic process.
Phospholipase-mediated release of choline
In simple terms: Enzymes cut choline out of membrane lipids so it can be broken down or reused.
Phospholipases, including phospholipase A2, C, and D, hydrolyze phosphatidylcholine to release free choline, phosphocholine, or glycerophosphocholine. These products can either be reutilized for lipid synthesis or directed toward catabolic degradation. In cancer cells, elevated phospholipase activity contributes to the high phosphocholine and total choline levels observed by magnetic resonance spectroscopy.
Oxidation of choline to betaine
In simple terms: Choline is oxidized to betaine, which donates methyl groups for other reactions.
In mitochondria, choline dehydrogenase oxidizes choline to betaine aldehyde, which is then oxidized to betaine by betaine aldehyde dehydrogenase. Betaine serves as a methyl donor in the methionine cycle, linking choline catabolism to folate-mediated one-carbon metabolism and epigenetic regulation. This oxidative branch is a major catabolic route for choline in liver and kidney.
Demethylation and one-carbon unit generation
In simple terms: The breakdown of choline-derived betaine releases methyl groups that feed into other metabolic cycles.
Betaine donates a methyl group to homocysteine to form methionine, a reaction catalyzed by betaine-homocysteine S-methyltransferase. This connects choline catabolism to the folate cycle and S-adenosylmethionine production, influencing DNA and histone methylation. The shuttling of methyl groups between folate and choline pathways is critical for maintaining methylation capacity.
Integration with lipid droplet and energy metabolism
In simple terms: Choline breakdown products influence how cells store and use fat.
Phosphatidylcholine metabolism, including catabolic steps, affects lipid droplet formation and stability. p53 suppresses lipid droplet-fueled tumorigenesis through regulation of phosphatidylcholine, indicating that choline catabolic flux is integrated with energy stress responses. This crosstalk highlights the role of choline catabolism in cellular lipid homeostasis and cancer metabolism.
Key Genes Involved in GO:0042426 choline catabolic process
The following genes and enzymes are central to choline catabolic process and its regulation, based on published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| CHKA | Choline kinase alpha; phosphorylates choline to phosphocholine | Rate-limiting for phosphatidylcholine synthesis; target in cancer metabolism |
| CHKB | Choline kinase beta; muscle-specific choline phosphorylation | Associated with muscular dystrophy and lipid metabolism |
| PCYT1A | CTP:phosphocholine cytidylyltransferase alpha; converts phosphocholine to CDP-choline | Rate-limiting enzyme of Kennedy pathway; regulates membrane synthesis |
| PCYT1B | CTP:phosphocholine cytidylyltransferase beta | Neuronal phosphatidylcholine synthesis |
| CHPT1 | Choline phosphotransferase 1; final step of phosphatidylcholine synthesis | Links choline metabolism to membrane lipid composition |
| PLA2G4A | Phospholipase A2; releases choline-containing lysophospholipids | Inflammatory signaling and cancer |
| PLD1 | Phospholipase D1; hydrolyzes phosphatidylcholine to choline and phosphatidic acid | Cell signaling and cancer progression |
| PLD2 | Phospholipase D2; similar to PLD1 | Membrane trafficking and oncogenic signaling |
| CHDH | Choline dehydrogenase; oxidizes choline to betaine aldehyde | Mitochondrial choline catabolism; linked to one-carbon metabolism |
| ALDH7A1 | Betaine aldehyde dehydrogenase; oxidizes betaine aldehyde to betaine | Betaine synthesis; mutations cause pyridoxine-dependent epilepsy |
| BHMT | Betaine-homocysteine S-methyltransferase; uses betaine to methylate homocysteine | Connects choline catabolism to methionine cycle |
| SLC44A1 | Choline transporter-like protein 1; mediates choline uptake | Substrate availability for catabolism |
| SLC44A2 | Choline transporter-like protein 2 | Choline transport in inner ear and blood cells |
| SLC5A7 | High-affinity choline transporter; neuronal choline uptake | Acetylcholine synthesis and neurotransmission |
| PEMT | Phosphatidylethanolamine N-methyltransferase; synthesizes phosphatidylcholine from PE | Alternative route to phosphatidylcholine; affects choline requirement |
| CEPT1 | Choline/ethanolamine phosphotransferase 1 | Phosphatidylcholine synthesis |
| LPCAT1 | Lysophosphatidylcholine acyltransferase 1 | Remodeling of phosphatidylcholine; cancer metabolism |
| GDPD5 | Glycerophosphodiester phosphodiesterase domain containing 5 | Degrades glycerophosphocholine to choline |
How Is choline catabolic process Regulated?
Choline catabolic process is regulated at multiple levels. The CDP-choline pathway is controlled by the rate-limiting enzyme CTP:phosphocholine cytidylyltransferase (PCYT1A), which is activated by membrane lipid composition and phosphorylation. Choline kinase expression is induced by growth factors and oncogenes, increasing phosphocholine levels in cancer. The oxidative catabolic branch via choline dehydrogenase and betaine aldehyde dehydrogenase is regulated by osmotic stress and methyl-donor availability. Additionally, p53 can suppress phosphatidylcholine metabolism and lipid droplet accumulation, indirectly modulating choline catabolic flux. Dietary choline availability and folate status also influence pathway activity through one-carbon metabolism feedback.
choline catabolic process and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| CHKA | Cancer; elevated phosphocholine | CRISPR knockout in cancer cell lines; metabolomics |
| PCYT1A | Cancer; membrane lipid synthesis | Point mutation of catalytic domain; lipidomics |
| CHDH | One-carbon metabolism; hyperhomocysteinemia | Knockout in hepatocytes; methionine cycle analysis |
| BHMT | Hyperhomocysteinemia; liver disease | Knock-in of human variant; betaine supplementation |
| SLC44A1 | Choline transport deficiency; neurodegeneration | Overexpression and knockout in neuronal cells |
Cancer metabolism and choline catabolism
Altered choline metabolism is a hallmark of cancer. Elevated phosphocholine and total choline compounds are detected by magnetic resonance spectroscopy in many tumors, reflecting increased choline kinase activity and phosphatidylcholine turnover. p53 suppresses lipid droplet-fueled tumorigenesis through phosphatidylcholine, linking choline catabolic pathways to tumor suppression. Targeting choline catabolic enzymes may therefore offer therapeutic opportunities in cancers with dysregulated lipid metabolism.
Neurodevelopmental and cognitive disorders
Choline is critical for neurodevelopment, and its catabolic and anabolic pathways influence acetylcholine synthesis and methylation reactions in the brain. Dietary choline deficiency during pregnancy is associated with cognitive deficits, and polymorphisms in choline metabolic genes may modify risk. The interplay between choline catabolism and folate metabolism further affects neurocognitive outcomes.
Cardiometabolic and liver disease
Choline catabolism contributes to methyl-group homeostasis and lipid metabolism, with implications for cardiometabolic health. Betaine, a product of choline oxidation, is used to lower homocysteine, and impaired choline catabolism may contribute to hyperhomocysteinemia and liver steatosis. Future directions in choline research highlight cardiometabolic health as a key area.
From choline catabolic process-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of CHKA reduce choline catabolic flux and tumor growth? | CRISPR knockout of CHKA in cancer cell lines and xenografts |
| How does a point mutation in PCYT1A affect phosphatidylcholine synthesis? | CRISPR point mutation knock-in in HEK293 or HepG2 cells |
| Can tagged CHDH track mitochondrial choline oxidation? | Knock-in of FLAG-tagged CHDH in hepatocytes |
| Does overexpression of SLC44A1 increase choline uptake and catabolism? | Doxycycline-inducible overexpression in neuronal cells |
| What is the effect of BHMT knockout on homocysteine levels? | CRISPR knockout in mouse liver or HepG2 cells |
| Can CRISPR library screening identify synthetic lethal partners of choline catabolic genes? | Genome-wide CRISPR knockout library in cancer cells |
How to Study the choline catabolic process Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Metabolomics (LC-MS) | Choline, phosphocholine, betaine levels | Quantify catabolic flux in cells and tissues |
| Magnetic resonance spectroscopy | Total choline compounds | Non-invasive cancer diagnosis and monitoring |
| CRISPR knockout screening | Gene dependencies and synthetic lethality | Identify modifiers of choline catabolism |
| RNA-seq | Transcriptional changes | Assess pathway gene expression after perturbation |
| Proteomics | Protein abundance and modifications | Study enzyme regulation in catabolic pathway |
| Lipid droplet imaging | Lipid storage dynamics | Visualize effects of choline catabolic genes |
| Choline uptake assay | Transport activity | Measure SLC44A1/SLC5A7 function |
| Betaine quantification | Methyl donor production | Assess oxidative catabolic branch |
Metabolomics and magnetic resonance spectroscopy
Choline catabolic process can be monitored by measuring choline, phosphocholine, glycerophosphocholine, and betaine using mass spectrometry-based metabolomics or magnetic resonance spectroscopy (MRS). MRS allows non-invasive detection of total choline compounds in tumors and is used clinically as a cancer biomarker.
CRISPR screening and functional genomics
Genome-wide CRISPR knockout or activation screens can identify genes that modulate choline catabolic flux and synthetic lethal interactions. For example, screens in cancer cells with high phosphocholine levels can reveal dependencies on choline kinase or phospholipases.
RNA-seq and proteomics
Transcriptomic and proteomic profiling of cells with perturbations in choline catabolic genes reveals downstream effects on lipid metabolism, one-carbon metabolism, and signaling pathways. RNA-seq can quantify expression changes in CHKA, PCYT1A, and BHMT, while proteomics can assess protein abundance and post-translational modifications.
Imaging and lipid droplet analysis
Fluorescence imaging of lipid droplets and phosphatidylcholine analogs can visualize the impact of choline catabolic perturbations on cellular lipid storage. Confocal microscopy with tagged enzymes (e.g., GFP-CHDH) can localize catabolic machinery to mitochondria or other compartments.
How CRISPR Can Be Used to Study GO:0042426 choline catabolic process
Knockout
CRISPR knockout of choline catabolic genes such as CHKA, PCYT1A, or CHDH enables loss-of-function studies to determine their role in phosphatidylcholine synthesis, one-carbon metabolism, and tumor growth. Knockout cell models can be used for metabolomic profiling and drug sensitivity assays.
Point Mutation
Point mutations in catalytic residues of choline kinase or cytidylyltransferase can dissect enzymatic mechanisms and identify separation-of-function phenotypes. CRISPR point mutation knock-in allows precise modeling of human variants associated with disease.
Knock-in
Knock-in of epitope tags (e.g., FLAG, HA) or fluorescent proteins into endogenous choline catabolic genes facilitates localization, interaction, and real-time activity studies. Knock-in of disease-associated alleles can model altered catabolic flux.
Overexpression
CRISPR activation or cDNA overexpression of choline transporters or catabolic enzymes can increase pathway flux, enabling gain-of-function studies in neurodevelopment and cancer. Inducible systems allow temporal control of choline catabolism.
How EDITGENE Supports choline catabolic process Research
Researchers studying choline catabolic process-related genes often need to determine whether a candidate gene is causally involved in choline breakdown, lipid metabolism, or disease. EDITGENE provides comprehensive CRISPR gene editing services to create precisely engineered cell models for such functional studies.
Contact EDITGENE today to design your custom CRISPR model for choline catabolic process research.
Frequently Asked Questions About choline catabolic process
What is choline catabolic process (GO:0042426)?
It is the set of biochemical reactions that break down choline, an amino alcohol essential for phospholipid and acetylcholine synthesis, as defined by GO:0042426.
What genes are involved in choline catabolic process?
Key genes include CHKA, PCYT1A, CHDH, ALDH7A1, BHMT, PLD1, and SLC44A1, which mediate choline phosphorylation, oxidation, and transport.
How is choline catabolism linked to cancer?
Altered choline metabolism, including increased phosphocholine, is a metabolic hallmark of cancer, and p53 suppresses lipid droplet-fueled tumorigenesis through phosphatidylcholine.
What is the role of choline catabolism in neurodevelopment?
Choline catabolism influences acetylcholine synthesis and one-carbon metabolism, affecting cognitive development and neurocognitive outcomes.
Which enzymes catalyze choline breakdown?
Choline dehydrogenase and betaine aldehyde dehydrogenase oxidize choline to betaine, while phospholipases release choline from phosphatidylcholine.
How can I study choline catabolic process in the lab?
Use CRISPR knockout, point mutation, knock-in, or overexpression models combined with metabolomics, MRS, RNA-seq, and proteomics.
What diseases are associated with choline catabolic defects?
Cancer, neurodevelopmental disorders, hyperhomocysteinemia, and cardiometabolic diseases have been linked to altered choline metabolism.
What is the CDP-choline pathway?
It is the Kennedy pathway for phosphatidylcholine synthesis, where choline is phosphorylated and converted to CDP-choline, intersecting with choline catabolism.
How does choline catabolism affect methylation?
Choline oxidation to betaine provides methyl groups for homocysteine remethylation, linking choline catabolism to folate-mediated one-carbon metabolism.
Can CRISPR screens identify choline catabolic regulators?
Yes, genome-wide CRISPR screens can uncover genes that modulate choline catabolism and synthetic lethal interactions in cancer.
Conclusion
Choline catabolic process (GO:0042426) is a fundamental biological pathway that breaks down choline into metabolites feeding phospholipid turnover, one-carbon metabolism, and neurotransmission. Its dysregulation is implicated in cancer, neurodevelopmental disorders, and cardiometabolic disease, making it a compelling research target. Advances in CRISPR gene editing and metabolomics now allow precise interrogation of choline catabolic genes in physiologically relevant models. EDITGENE supports this research with comprehensive CRISPR services, from knockout and point mutation to knock-in, overexpression, and library screening, enabling causal dissection of choline catabolic process in health and disease.
References
- 1. Xu X et al.. 2024. p53 suppresses lipid droplet-fueled tumorigenesis through phosphatidylcholine.. J Clin Invest 134(4) PMID: 38194288
- 2. Boldon N et al.. 2026. Choline, a nexus for neurocognitive nutrients: A narrative review.. Nutr Res 151:139-176 PMID: 42250568
- 3. Fagone P et al.. 2013. Phosphatidylcholine and the CDP-choline cycle.. Biochim Biophys Acta 1831(3):523-32 PMID: 23010477
- 4. Paules EM et al.. 2025. Future Directions in Choline: From Neurodevelopment to Cardiometabolic Health.. Nutrients 17(22) PMID: 41305668
- 5. Michel V et al.. 2006. Choline transport for phospholipid synthesis.. Exp Biol Med (Maywood) 231(5):490-504 PMID: 16636297
- 6. Burns BC et al.. 2025. Choline-An Essential Nutrient with Health Benefits and a Signaling Molecule.. Int J Mol Sci 26(15) PMID: 40806292
- 7. Bortz J et al.. 2025. The Shuttling of Methyl Groups Between Folate and Choline Pathways.. Nutrients 17(15) PMID: 40806080
- 8. Glunde K et al.. 2015. Choline metabolism-based molecular diagnosis of cancer: an update.. Expert Rev Mol Diagn 15(6):735-47 PMID: 25921026
